Nisa Investment Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.43K Sell
850
-808
-49% -$6.11K ﹤0.01% 2403
2025
Q1
$9.15K Buy
1,658
+1,123
+210% +$6.2K ﹤0.01% 2120
2024
Q4
$3.08K Sell
535
-2,292
-81% -$13.2K ﹤0.01% 2383
2024
Q3
$29.3K Sell
2,827
-59
-2% -$611 ﹤0.01% 1784
2024
Q2
$37.4K Buy
2,886
+59
+2% +$765 ﹤0.01% 1743
2024
Q1
$49.4K Hold
2,827
﹤0.01% 1658
2023
Q4
$26.6K Buy
2,827
+2,281
+418% +$21.5K ﹤0.01% 1790
2023
Q3
$6.1K Buy
546
+36
+7% +$402 ﹤0.01% 2266
2023
Q2
$10.9K Buy
510
+333
+188% +$7.13K ﹤0.01% 2243
2023
Q1
$7K Sell
177
-750
-81% -$29.7K ﹤0.01% 2202
2022
Q4
$43K Sell
927
-9
-1% -$417 ﹤0.01% 1824
2022
Q3
$42K Sell
936
-271
-22% -$12.2K ﹤0.01% 1805
2022
Q2
$57K Buy
1,207
+750
+164% +$35.4K ﹤0.01% 1692
2022
Q1
$33K Sell
457
-1,077
-70% -$77.8K ﹤0.01% 1943
2021
Q4
$91K Sell
1,534
-2,886
-65% -$171K ﹤0.01% 1546
2021
Q3
$251 Sell
4,420
-2,014
-31% -$114 ﹤0.01% 1328
2021
Q2
$283 Hold
6,434
﹤0.01% 1298
2021
Q1
$317 Hold
6,434
﹤0.01% 1317
2020
Q4
$271K Buy
6,434
+2,762
+75% +$116K ﹤0.01% 1355
2020
Q3
$168K Buy
3,672
+3,032
+474% +$139K ﹤0.01% 1369
2020
Q2
$32K Buy
640
+500
+357% +$25K ﹤0.01% 1672
2020
Q1
$7K Buy
140
+50
+56% +$2.5K ﹤0.01% 1904
2019
Q4
$6K Hold
90
﹤0.01% 1909
2019
Q3
$5K Hold
90
﹤0.01% 1895
2019
Q2
$8K Hold
90
﹤0.01% 1807
2019
Q1
$9K Hold
90
﹤0.01% 1780
2018
Q4
$6K Hold
90
﹤0.01% 1761
2018
Q3
$8K Buy
+90
New +$8K ﹤0.01% 1779